Ironing out the role of ferroptosis in immunity DOI Creative Commons
Hannah N. Bell, Brent R. Stockwell, Weiping Zou

и другие.

Immunity, Год журнала: 2024, Номер 57(5), С. 941 - 956

Опубликована: Май 1, 2024

Ferroptosis is a type of regulated cell death that drives the pathophysiology many diseases. Oxidative stress detectable in types death, but only ferroptosis involves lipid peroxidation and iron dependency. originates propagates from several organelles, including mitochondria, endoplasmic reticulum, Golgi, lysosomes. Recent data have revealed immune cells can both induce undergo ferroptosis. A mechanistic understanding how regulates immunity critical to controls responses this dysregulated disease. Translationally, more work needed produce ferroptosis-modulating immunotherapeutics. This review focuses on role immune-related diseases, infection, autoimmune cancer. We discuss immunity, regulation contributes disease pathogenesis, targeting may lead novel therapies.

Язык: Английский

The microbiome and human cancer DOI
Gregory D. Sepich‐Poore, Laurence Zitvogel, Ravid Straussman

и другие.

Science, Год журнала: 2021, Номер 371(6536)

Опубликована: Март 25, 2021

Microbial roles in cancer formation, diagnosis, prognosis, and treatment have been disputed for centuries. Recent studies provocatively claimed that bacteria, viruses, and/or fungi are pervasive among cancers, key actors immunotherapy, engineerable to treat metastases. Despite these findings, the number of microbes known directly cause carcinogenesis remains small. Critically evaluating building frameworks such evidence light modern biology is an important task. In this Review, we delineate between causal complicit trace common themes their influence through host's immune system, herein defined as immuno-oncology-microbiome axis. We further review intratumoral approaches manipulate gut or tumor microbiome while projecting next phase experimental discovery.

Язык: Английский

Процитировано

878

Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8+ T cell immunity DOI Creative Commons

Yao He,

Liuhui Fu, Yiping Li

и другие.

Cell Metabolism, Год журнала: 2021, Номер 33(5), С. 988 - 1000.e7

Опубликована: Март 23, 2021

Язык: Английский

Процитировано

447

Microbiome and cancer DOI Creative Commons
Nyssa Cullin, Camila Azevedo Antunes, Ravid Straussman

и другие.

Cancer Cell, Год журнала: 2021, Номер 39(10), С. 1317 - 1341

Опубликована: Сен. 9, 2021

Язык: Английский

Процитировано

362

Role of microbiota-derived short-chain fatty acids in cancer development and prevention DOI Open Access
Rasoul Mirzaei, Azam Afaghi, Sajad Babakhani

и другие.

Biomedicine & Pharmacotherapy, Год журнала: 2021, Номер 139, С. 111619 - 111619

Опубликована: Апрель 24, 2021

Following cancer, cells in a particular tissue can no longer respond to the factors involved controlling cell survival, differentiation, proliferation, and death. In recent years, it has been indicated that alterations gut microbiota components, intestinal epithelium, host immune system are associated with cancer incidence. Also, demonstrated short-chain fatty acids (SCFAs) generated by vitally crucial homeostasis as they contribute modulation of histone deacetylases (HDACs), resulting effected attachment, immigration, cytokine production, chemotaxis, programmed Therefore, manipulation SCFA levels tract structure be potentially taken into consideration for treatment/prevention. current study, we will explain most findings on detrimental or protective roles SFCA (particularly butyrate, propionate, acetate) several cancers, including bladder, colon, breast, stomach, liver, lung, pancreas, prostate cancers.

Язык: Английский

Процитировано

291

Cancer and the Microbiome—Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy DOI
Vyara Matson,

Carolina Soto Chervin,

Thomas F. Gajewski

и другие.

Gastroenterology, Год журнала: 2020, Номер 160(2), С. 600 - 613

Опубликована: Ноя. 28, 2020

Язык: Английский

Процитировано

280

Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies DOI Creative Commons
Yuting Lu, Xiangliang Yuan, Miao Wang

и другие.

Journal of Hematology & Oncology, Год журнала: 2022, Номер 15(1)

Опубликована: Апрель 29, 2022

The gut microbiota have long been recognized to play a key role in human health and disease. Currently, several lines of evidence from preclinical clinical research gradually established that the can modulate antitumor immunity affect efficacy cancer immunotherapies, especially immune checkpoint inhibitors (ICIs). Deciphering underlying mechanisms reveals reprogram tumor microenvironment (TME) by engaging innate and/or adaptive cells. Notably, one primary modes which is means metabolites, are small molecules could spread their initial location impact local systemic response promote ICI efficiency. Mechanistic exploration provides novel insights for developing rational microbiota-based therapeutic strategies manipulating microbiota, such as fecal transplantation (FMT), probiotics, engineered microbiomes, specific microbial augment advance age utilization precision medicine.

Язык: Английский

Процитировано

279

Short-chain fatty acids: linking diet, the microbiome and immunity DOI
Elizabeth R. Mann, Ying Ka Lam, Holm H. Uhlig

и другие.

Nature reviews. Immunology, Год журнала: 2024, Номер 24(8), С. 577 - 595

Опубликована: Апрель 2, 2024

Язык: Английский

Процитировано

230

Generation of systemic antitumour immunity via the in situ modulation of the gut microbiome by an orally administered inulin gel DOI
Kai Han, Jutaek Nam,

Jin Xu

и другие.

Nature Biomedical Engineering, Год журнала: 2021, Номер 5(11), С. 1377 - 1388

Опубликована: Июнь 24, 2021

Язык: Английский

Процитировано

172

Gut microbiota-derived short-chain fatty acids and colorectal cancer: Ready for clinical translation? DOI

Huiqin Hou,

Danfeng Chen, Kexin Zhang

и другие.

Cancer Letters, Год журнала: 2021, Номер 526, С. 225 - 235

Опубликована: Ноя. 26, 2021

Язык: Английский

Процитировано

155

Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer DOI Creative Commons
Shilong Zhang, Yuqin Mao, Zhengyan Zhang

и другие.

Theranostics, Год журнала: 2021, Номер 11(9), С. 4155 - 4170

Опубликована: Янв. 1, 2021

Background: Anti-PD-1-based immunotherapy has emerged as a promising therapy for several cancers. However, it only benefits small subset of colorectal cancer (CRC) patients. Mounting data supports the pivotal role gut microbiota in shaping immune system. Pectin, widely consumed soluble fiber, been reported to ameliorate imbalance microbiota. Therefore, we aimed explore effect and underlying mechanisms pectin improving anti-PD-1 mAb efficacy. Methods: The C57BL/6 mice were treated with broad-spectrum antibiotic (ATB) cocktail depleted endogenous subsequently humanized feces from healthy controls or newly diagnosed CRC antitumor efficacies combined without assessed using these mice. Flow cytometry immunohistochemistry (IHC) conducted investigate tumor microenvironment after treatment. profiles short-chain fatty acids (SCFAs) levels determined by 16S ribosomal RNA (16S rRNA) gene sequencing gas chromatography-mass spectrometry (GC-MS), respectively. on efficacy supplement was further tested fecal transplantation (FMT). Results: largely impaired patients compared those controls. significantly enhanced tumor-bearing patient IHC analysis revealed increased T cell infiltration activation plus pectin. In vivo depletion CD8+ cells diminished anti-tumor rRNA showed that microbial diversity beneficially regulated composition. addition, identified unique bacterial modules enriched + group, which composed butyrate-producing bacteria indicative good response immunotherapy. Meanwhile, GC-MS altered level SCFA butyrate. Furthermore, butyrate, main product dietary fiber fermentation, found be sufficient promote thus enhance mAb. FMT demonstrated effects dependent Importantly, beneficial confirmed resistance Conclusion: Pectin facilitated via regulating microenvironment, potentially mediated metabolite

Язык: Английский

Процитировано

135